NeoStem Up For $18 Million Melanoma Award from California
California's stem cell agency is expected to make an $18 million bet this week on a treatment by NeoStem, Inc., for a skin cancer that kills 10,000 persons a year in the United States alone.
Up for approval on Thursday is the company's application for an award to assist in a late stage trial that could produce a commercial product before the agency is ex…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.